Stereotactic Radiotherapy for Stage I Small Cell Lung Cancer

被引:15
|
作者
Verma, Vivek [1 ]
Simone, Charles B., II [2 ]
Zhen, Weining [1 ]
机构
[1] Univ Nebraska Med Ctr, Dept Radiat Oncol, 987521 Nebraska Med Ctr,Ground Floor, Omaha, NE 68198 USA
[2] Univ Penn, Dept Radiat Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA
来源
ONCOLOGIST | 2016年 / 21卷 / 02期
关键词
BODY RADIATION-THERAPY; ABLATIVE RADIOTHERAPY; PHASE-II; DISEASE; SURGERY; TRIAL; CHEMOTHERAPY; LOBECTOMY; CARCINOMA; RESECTION;
D O I
10.1634/theoncologist.2015-0348
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:131 / 133
页数:3
相关论文
共 50 条
  • [41] Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: Patterns of failure
    Andratschke, Nicolaus
    Zimmermann, Frank
    Boehm, Eva
    Schill, Sabine
    Schoenknecht, Christine
    Thamm, Reinhard
    Molls, Michael
    Nieder, Carsten
    Geinitz, Hans
    RADIOTHERAPY AND ONCOLOGY, 2011, 101 (02) : 245 - 249
  • [42] Clinical results of stereotactic body radiotherapy for Stage I small-cell lung cancer: a single institutional experience
    Shioyama, Yoshiyuki
    Nakamura, Katsumasa
    Sasaki, Tomonari
    Ohga, Saiji
    Yoshitake, Tadamasa
    Nonoshita, Takeshi
    Asai, Kaori
    Terashima, Koutarou
    Matsumoto, Keiji
    Hirata, Hideki
    Honda, Hiroshi
    JOURNAL OF RADIATION RESEARCH, 2013, 54 (01) : 108 - 112
  • [43] Stereotactic body radiotherapy (SBRT) for the treatment of inoperable stage I non-small cell lung cancer patients
    L. Ceniceros
    J. Aristu
    E. Castañón
    C. Rolfo
    J. Legaspi
    A. Olarte
    G. Valtueña
    M. Moreno
    I. Gil-Bazo
    Clinical and Translational Oncology, 2016, 18 : 259 - 268
  • [44] Opportunities and limitations of fractionated stereotactic body radiotherapy for stage I/II non-small-cell lung cancer
    Adebahr, Sonja
    Bernhardt, Denise
    ONKOLOGIE, 2022, 28 (12): : 1051 - 1058
  • [45] Preservation of pulmonary function following stereotactic body radiotherapy for stage I non-small cell lung cancer
    Williams, MD
    McGarry, RC
    Timmerman, R
    CHEST, 2003, 124 (04) : 196S - 196S
  • [46] Stereotactic Ablative Radiotherapy Using CyberKnife for Stage I Non-small-cell Lung Cancer: A Retrospective Analysis
    Hayashi, Kazuhiko
    Suzuki, Osamu
    Shiomi, Hiroya
    Nakai, Masataka
    Fujiwara, Kei
    Nakanishi, Erina
    Tatekawa, Shotaro
    Hirata, Takero
    Tamari, Keisuke
    Hirata, Haruhiko
    Funaki, Soichiro
    Seo, Yuji
    Takeda, Yoshito
    Isohashi, Fumiaki
    Shintani, Yasushi
    Ogawa, Kazuhiko
    ANTICANCER RESEARCH, 2022, 42 (01) : 321 - 327
  • [47] Clinical outcomes of CyberKnife stereotactic body radiotherapy for peripheral stage I non-small cell lung cancer
    Shen, Ze-Tian
    Wu, Xin-Hu
    Li, Bing
    Zhu, Xi-Xu
    MEDICAL ONCOLOGY, 2015, 32 (03)
  • [48] Outcome of Stereotactic Body Radiotherapy for Patients with Histologically Proven Stage I Non-Small-Cell Lung Cancer
    Ogata, T.
    Kosaka, Y.
    Imagumbai, T.
    Ogura, K.
    Hattori, T.
    Hiraoka, S.
    Kokubo, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E524 - E524
  • [49] Outcomes of Stereotactic Ablative Radiotherapy in Patients With Potentially Operable Stage I Non-Small Cell Lung Cancer
    Lagerwaard, Frank J.
    Verstegen, Naomi E.
    Haasbeek, Cornelis J. A.
    Slotman, Ben J.
    Paul, Marinus A.
    Smit, Egbert F.
    Senan, Suresh
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (01): : 348 - 353
  • [50] Stereotactic ablative radiotherapy versus lobectomy for stage I non-small cell lung cancer: A systematic review
    Wang, Siwei
    Wang, Xiaoxiao
    Zhou, Qing
    Xu, Youtao
    Xia, Wenjia
    Xu, Weizhang
    Ma, ZhiFei
    Qiu, Mantang
    You, Ran
    Xu, Lin
    Yin, Rong
    THORACIC CANCER, 2018, 9 (03) : 337 - 347